Key result
Metabolomic profiling of DVT yields inconsistent expression patterns requiring analysis of influencing factors.
Why the study?
Currently, metabolomic profiles of deep vein thrombosis have yielded inconsistent expression patterns.
Metabolomics is a promising tool for DVT screening and understanding its pathophysiology, though current studies show inconsistent expression patterns.
Inconsistent DVT metabolomic results caution against clinical use; leaves open standardization of methods to identify influencing factors.
Deep vein thrombosis (DVT) of the lower extremities is one of the most common peripheral vascular diseases, with significant complications and sequelae. Metabolomics aims to identify small molecules in biological samples. It can serve as a promising method for screening compounds that can be used for early disease detection, diagnosis, treatment response prediction, and prognosis. In addition, high-throughput metabolomics screening can yield significant insights into the pathophysiological pathways of DVT. Currently, the metabolomic profiles of DVT have yielded inconsistent expression patterns. This article examines the recent advancements in metabolomic studies of DVT and analyzes the factors that may influence the results.
No takes yet. Share an insight, caveat, or question.
Jiang et al. (2023) conducted a review in Deep vein thrombosis (DVT). Metabolomic profiling was evaluated. Metabolomic profiling of deep vein thrombosis has yielded inconsistent expression patterns, highlighting the need to analyze factors influencing these results.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: